Cure Alzheimer's Fund Receives $50 Million Gift to Support Research

Largest donation in the non-profit organization's 20-year history

WELLESLEY HILLS, Mass., Sept. 26, 2025 /PRNewswire/ -- Today, Cure Alzheimer's Fund (CureAlz) announced it has received a $50 million gift from The Cardinal Family Fund, the largest contribution in its 20-year history of funding Alzheimer's disease research. Over the next five years, this generous and transformational gift will drive progress in three areas:

• THE CARDINAL FAMILY SCHOLARS FUND FOR ALZHEIMER'S DISEASE RESEARCH: The Cardinal Family Scholars Fund for Alzheimer's Disease Research will provide extraordinary support to early and mid-career scientists emerging as the next generation of Alzheimer's disease leaders. The program will include funding research, personnel, lab infrastructure and professional development.
• THE CARDINAL FAMILY PRECISION MEDICINE RESEARCH FUND: With the guidance of our external scientific leadership, CureAlz has always sought to fund research that will yield safe and effective prevention and therapeutics for every member of the Alzheimer's community. The Cardinal Family Precision Medicine Research Fund will advance investigations into biological and other factors that drive differences in Alzheimer's disease risk and progression for subgroups within our community so that we can end this disease for everyone.
• THE CARDINAL FAMILY EMERGENCY RELIEF FUND: The Cardinal Family Emergency Relief Fund will sustain progress against Alzheimer's disease by providing rapid support for critical research data and infrastructure, including the scientific workforce, in response to federal funding disruptions and cancellations.

"This extraordinary gift represents remarkable generosity and the Cardinal Family's belief in our shared goal of funding research that will lead to therapeutic solutions and, one day, a cure for Alzheimer's disease," said Henry McCance, Chair and Co-Founder of Cure Alzheimer's Fund.

"This gift comes at a pivotal moment for Alzheimer's research, ensuring that critical momentum continues and accelerating discoveries that bring us closer to effective treatments and a cure," said Meg Smith, Chief Executive Officer of Cure Alzheimer's Fund. "We are all profoundly grateful to The Cardinal Family Fund and honored by their trust, and we look forward to upholding the tremendous responsibility that accompanies such extraordinary support." 

About Cure Alzheimer's Fund
Cure Alzheimer's Fund (CureAlz) is a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease. Since its founding in 2004, CureAlz has provided $235 million to more than 300 of the world's leading researchers and has achieved a 100% perfect score and a Four-Star rating for 13 consecutive years from Charity Navigator. Our Board of Directors, Trustees and a core group of other donors direct their donations to our overhead expenses so that 100% of general donations go to our research program. For more information, visit CureAlz.org.

Media Contact: Barbara Chambers
[email protected], 978-417-9890

SOURCE Alzheimer's Disease Research Foundation